Skip to content

Diaphragm Response in Elderly for Acute Monitoring

Using Diaphragmatic Ultrasound to Predict Acute Respiratory Distress (ARD) in Patients Aged 75 and Over Admitted to the Emergency Department for Acute Dyspnea : Prospective Multicenter Study.

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07132268
Acronym
DREAM
Enrollment
145
Registered
2025-08-20
Start date
2026-10-01
Completion date
2028-10-01
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Dyspnea, Acute Respiratory Failure, Diaphragmatic Ultrasound

Brief summary

Acute dyspnea is a common cause of emergency department admissions among elderly patients. Acute respiratory failure is often multifactorial and requires rapid and reliable evaluation. Currently, management relies on clinical, biological, and radiological assessments, but diaphragmatic ultrasound could provide an additional tool for real-time respiratory function evaluation. This study aims to integrate this non-invasive technology into the initial assessment of patients to improve care pathways. Hypothesis : Diaphragmatic ultrasound enables reliable assessment of respiratory function and can predict the need for mechanical ventilation.

Interventions

None listed

Sponsors

Centre Hospitalier de Bethune
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged ≥ 75 years * Emergency admission for acute dyspnea * Requiring an emergency ultrsoung.

Exclusion criteria

* Acute respiratory distress requiring immediate invasive or non-invasive ventilation * Respiratory rate ≥ 25 breaths/min, and/or SpO2 ≤ 90% on room air, and/or PaO2 ≤ 60 mmHg * Known diaphragmatic paralysis * Patients with degenerative neuromuscular disease * State of shock: systolic blood pressure \< 90 mmHg and/or mean arterial pressure \< 65 mmHg and/or presence of skin mottling and/or CTR \> 3s * Lactate levels \> 2 mmol/L * Hypercapnic respiratory acidosis (pH \< 7.38 and PaCO2 \> 45 mmHg) * Dyspnea due to metabolic acidosis (e.g., diabetic ketoacidosis, renal failure) * Dyspnea of traumatic origin * Refusal to participate or inability to provide informed consent * Patients deprived of liberty * Patients under guardianship or curatorship

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of a severe acute respiratory event within 7 days of admissionWITHIN 7 DAYS OF ADMISSION* Placement on invasive mechanical ventilation (intubation) or non invasive ventilation (NIV, high-flow oxygen therapy), * Respiratory death, confirmed by an independent adjudication committee blinded to the ultrasound results. Explanatory variable: The presence of impaired diaphragmatic function at admission will be defined by: * a Tdi (tele-inspiratory thickness) \<10%, and/or * a diaphragmatic excursion \<10 mm.

Secondary

MeasureTime frameDescription
Measurement of diaphragmatic excursion AND Etiology of acute dyspneawithin 7 daysTo study the association between diaphragmatic excursion curve parameters (EDR, inspiratory time, expiratory time, etc.) and the etiology of acute dyspnea in patients aged 75 years and older admitted for acute dyspnea
To evaluate the contribution of diaphragmatic ultrasound to the NEWS2 score performed on admission in predicting the occurrence of acute respiratory distress within 7 days.within 7 daysThe discriminatory power of the NEWS2 score in predicting the occurrence of acute respiratory distress, the discriminatory power of the NEWS2 score combined with impaired diaphragmatic function on admission ultrasound. NEWS 2 : The higher the score, the greater the risk of clinical deterioration. 0-4 : low risk Score of 3 in any individual parameter : low-medium 5-6 : moderate risk \> or = 7 : high risk

Countries

France

Contacts

CONTACTAlain-Eric DUBART, Doctor
adubart@ch-bethune.fr03.21.64.42.81
PRINCIPAL_INVESTIGATORAlain-Eric DUBART

Centre Hospitalier de Béthune-Beuvry

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026